Positive CHMP Opinion on Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with relapsed or refractory diffuse large B-cell Lymphoma-MedSci.cn

Positive CHMP Opinion on Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with relapsed or refractory diffuse large B-cell Lymphoma

[Anonymous]

TRANSFUSION MEDICINE AND HEMOTHERAPY, 2021; 48 (4): 263

科室
- - 订阅+
  - 更多科室
工具
服务